On October 30, 2025, in Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., Nos. 2025-1210, 2025-1211, the US Court of Appeals for the ...
MERCK SERONO S.A. v. HOPEWELL PHARMA VENTURES, INC. - Before Hughes, Linn, and Cunningham. Appeal from the Patent Trial and Appeal Board.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...
Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection.
In 2014, the Delaware Supreme Court issued a ruling that largely ended the practice of nuisance lawsuits where most ...
A new study provides more evidence that many patients with early-stage breast cancer may avoid sentinel lymph node surgery ...
Allied Market Research published a report, titled, "Immunostimulant Market by Product Type (Vaccines, Colony Stimulating Factors, ...
Ability Biotherapeutics, a biotechnology company advancing logic-gated antibody therapies for cancer and autoimmune diseases, ...
On paper, cultivated meat looks like a no-brainer. Unlike plant- or fungi-based options, it has the allure of “real” meat ...
MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS ...
Physiomics ( ($GB:PYC) ) has shared an announcement. Physiomics plc announced a new contract with Numab Therapeutics AG to support the ...
More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback